Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.

You are here: Home

Monday25 March 2019

What is HITV? HITV is based on immunology that harnesses our immune system’s innate and adaptive ability to combat diseases. It is a patient-derived active cell-based immunotherapy for patients with metastatic or late-stage cancer that has been found highly effective when used in combination with radiotherapy.


HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.

FacebookTwitterGoogle Bookmarks